Formononetin, derived from Pueraria Mirifica, has demonstrated in some animal and in vitro studies the ability to mimic the biological activity of estrogen, modulate the insulin signaling pathway, ameliorate insulin resistance, and regulate the secretion of ovarian hormones. The gene discussed is INS; the disease is Insulin resistance.